ribavirin has been researched along with Bacterial Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anagnostou, O; Andreadis, I; Deutsch, M; Kalafateli, M; Ketikoglou, I; Manolakopoulos, S; Mela, M; Papatheodoridis, G; Pectasides, D; Schini, M; Striki, A; Triantos, C | 1 |
| Azuma, K; Dohmen, K; Furusyo, N; Hayashi, J; Kajiwara, E; Kawano, A; Kotoh, K; Nakamuta, M; Nomura, H; Ogawa, E; Satoh, T; Shimoda, S; Takahashi, K; Tanabe, Y | 1 |
| Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Huang, JF; Lin, ZY; Wang, LY; Yang, JF; Yu, ML | 1 |
| Carrión, JA; Crespo, G; Forns, X; García-Valdecasas, JC; Martínez-Bauer, E; Navasa, M; Pérez-del-Pulgar, S; Ramírez, S | 1 |
| Roche, B; Samuel, D | 1 |
| Battezzati, PM; Benetti, A; Capsoni, F; Gershwin, ME; Giorgini, A; Lleó, A; Malinverno, F; Ongari, AM; Podda, M; Rossaro, L; Selmi, C; Zuin, M | 1 |
| Askar, M; Avery, R; Corey, R; Eghtesad, B; Fung, J; Lopez, R; Miller, C; Pidwell, D; Thomas, D; Zein, NN | 1 |
| de Knegt, RJ; Hansen, BE; Janssen, HL; Roomer, R | 1 |
| Aichelburg, MC; Breitenecker, F; Ferenci, P; Heil, PM; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Scherzer, TM; Schuster, C | 1 |
| Nicod, LP | 1 |
| Fergie, J; Purcell, K | 1 |
| James, DG | 1 |
2 review(s) available for ribavirin and Bacterial Disease
| Article | Year |
|---|---|
[Infectious complications of lung and heart-lung transplantation].
Topics: Acyclovir; Antibiotic Prophylaxis; Antifungal Agents; Antiviral Agents; Bacterial Infections; Chemoprevention; Cytomegalovirus Infections; Ganciclovir; Graft Survival; Heart-Lung Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Lung Transplantation; Lymphoproliferative Disorders; Mycobacterium Infections, Nontuberculous; Nocardia Infections; Pneumonia, Pneumocystis; Respiratory Syncytial Virus Infections; Ribavirin; Survival Rate; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Tumor Virus Infections; Virus Diseases | 1996 |
Virus infections.
Topics: Adrenal Cortex Hormones; Amantadine; Animals; Anti-Bacterial Agents; Bacterial Infections; Cytarabine; Deoxyglucose; gamma-Globulins; Humans; Idoxuridine; Immunotherapy; Interferon Inducers; Methisazone; Mice; Rabbits; Ribavirin; Vaccination; Viral Vaccines; Virus Diseases | 1976 |
2 trial(s) available for ribavirin and Bacterial Disease
| Article | Year |
|---|---|
Bacterial infection as an adverse effect of telaprevir-based triple therapy for chronic hepatitis C infection.
Topics: Adult; Aged; Antiviral Agents; Bacterial Infections; Biomarkers; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2015 |
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis.
Topics: Adult; Aged; Antiviral Agents; Bacterial Infections; CD11b Antigen; Chemotaxis, Leukocyte; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Macrophage-1 Antigen; Male; Middle Aged; Monocytes; Neutrophils; Phagocytosis; Polyethylene Glycols; Reactive Oxygen Species; Recombinant Proteins; Ribavirin; Time Factors | 2009 |
8 other study(ies) available for ribavirin and Bacterial Disease
| Article | Year |
|---|---|
Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirin.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Bacterial Infections; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Retrospective Studies; Ribavirin; Young Adult | 2014 |
Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice.
Topics: Adult; Aged; Antiviral Agents; Bacterial Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome; Young Adult | 2009 |
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.
Topics: Adult; Aged; Antiviral Agents; Bacterial Infections; Carcinoma, Hepatocellular; Female; Hepatitis C; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Peritonitis; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Safety; Time Factors; Viral Load; Waiting Lists; Young Adult | 2009 |
Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological results.
Topics: Antiviral Agents; Bacterial Infections; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Safety; Waiting Lists | 2009 |
Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.
Topics: Antiviral Agents; Bacterial Infections; Drug Resistance, Viral; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Killer Cells, Natural; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Postoperative Complications; Receptors, KIR; Receptors, KIR2DL2; Recombinant Proteins; Recurrence; Ribavirin | 2009 |
Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Bacterial Infections; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors | 2010 |
The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV.
Topics: Adult; Anti-Retroviral Agents; Antiviral Agents; Bacterial Infections; CD4-Positive T-Lymphocytes; Female; Hepatitis C, Chronic; HIV Infections; Humans; Incidence; Interferons; Leukocyte Count; Male; Middle Aged; Neutrophils; Opportunistic Infections; Ribavirin | 2012 |
Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections.
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacillus; Bacterial Infections; Bronchiolitis; Child, Hospitalized; Female; Hospitals, Pediatric; Humans; Incidence; Infant; Infant, Newborn; Male; Medical Records; Pneumonia, Bacterial; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Retrospective Studies; Ribavirin; Staphylococcus; Staphylococcus epidermidis; Texas | 2002 |